Dr. Chalasani currently serves as David W. Crabb Professor of Medicine and Cellular &Integrative physiology at Indiana University School of Medicine and is the Director of its Division of Gastroenterology and Hepatology. He completed his medical education in India and subsequently completed internal medicine residency and gastroenterology and hepatology subspecialty training at Emory University in Atlanta. He is a practicing hepatologist and is heavily engaged in clinical and translational liver disease research.
Two broad themes to his research focus are nonalcoholic fatty liver disease and idiosyncratic drug induced liver injury and he has made several important contributions to both of these areas. He is the Associate Editor for Gastroenterology and he has previously served or currently serving on the editorial board of many journals including Gastroenterology, Hepatology, Clinical Gastroenterology and Hepatology, Journal of Hepatology, American Journal of Medicine, Journal of Clinical Gastroenterology, and Nature Reviews Gastroenterology & Hepatology. He has been funded by the National Institutes of Health since 1998 for conducting investigations related to liver disease. Currently, he is the PI for two NIH U01 awards and one NIH K24 award, Co-PI for one NIH U01, and co-investigator for two NIH R01 awards. He has published over 200 original publications, 30 text book chapters and 26 editorials and commentaries. He is the lead author for the AASLD, AGA, and ACG multisociety practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. He coedited a text book “Alcoholic and Nonalcoholic Fatty Liver Disease (Springer). He is also the lead author for the ACG Practice Guideline on the diagnosis and management of idiosyncratic drug induced liver injury published in the American Journal of Gastroenterology in July 2014.